# A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%

> **NCT01426867** · PHASE2 · COMPLETED · sponsor: **Alcon Research** · enrollment: 103 (actual)

## Conditions studied

- Open-Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension
- **DRUG:** Brinzolamide ophthalmic suspension, 1%
- **DRUG:** Brimonidine tartrate ophthalmic solution, 0.2%

## Key facts

- **NCT ID:** NCT01426867
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2013-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01426867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01426867, "A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01426867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*